Transcatheter arterial infusion chemotherapy using miriplatin in patients with advanced hepatocellular carcinoma: Prospective randomized study, Lip-TAI vs. Lip+DSM-TAI
Not Applicable
- Conditions
- hepatocellular carcinoma
- Registration Number
- JPRN-UMIN000004526
- Lead Sponsor
- Department of Gastroenterology and Hepatology, Yamaguchi Univercity Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1) Parients with severe complicating disease except chronic hepatitis or liver cirrhosis. 2) Patients with active double cancer. 3) The patient with the anamnesis of the hypersensitivity. 4) A pregnant woman, or woman who may pregnant and who are nursing. 5) Patients who were disqualified by doctor in attendance.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Time-to-progression
- Secondary Outcome Measures
Name Time Method Tumor response, overall survival, and safety